Figure 2.
Reduction of left ventricular end‐diastolic volume (EDV) in the POSEIDON study. MDCT images (4 chamber and short axis view) of a patient with chronic ischemic cardiomyopathy (A) before (EDV 176.1 mL) and (B) after transendocardial stem cell injection (TESI) with 20 million autologous mesenchymal stem cells (EDV 136.8 mL). MDCT indicates multi‐detector computer tomography; POSEIDON, PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis.